Product Information

CYPROHEPTADINE 4 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0662 per EA under NDC 16571080501. Its NADAC has been published 213 times since Jun 1, 2022.

CYPROHEPTADINE 4 MG TABLET

Cyproheptadine Hydrochloride
$0.0662per EA

Strength

4 mg/1

NDC

16571080501

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

6/17/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA207555

On Market Since

2/9/2022

Price Statistics

The NADAC for CYPROHEPTADINE 4 MG TABLET has been published 213 times since Jun 1, 2022, and over the history we have for it it has declined 27.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0662 per EA
All-time high$0.1072 (Mar 13, 2024)
All-time low$0.0644 (Apr 22, 2026)
52-week high$0.0836
52-week low$0.0644
Median price$0.0836
Average price$0.0833
Largest weekly change-22.4% (Nov 20, 2024)
Weeks tracked213
Tracking sinceJun 1, 2022

Price History

1W

0.0%

1M

+1.3%

3M

-0.0%

6M

+1.9%

1Y

-20.8%

3Y

-31.9%

5Y

N/A

All

-27.9%

Generic Alternatives

The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of CYPROHEPTADINE 4 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for CYPROHEPTADINE 4 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.0662 per EA (NDC 16571080501), effective Jun 24, 2026.

How has the price of CYPROHEPTADINE 4 MG TABLET changed over time?

Over the history we have for it, the NADAC for CYPROHEPTADINE 4 MG TABLET has declined 27.9%. It has been tracked across 213 weekly CMS publications since Jun 1, 2022.

What are the highest and lowest recorded NADAC prices for CYPROHEPTADINE 4 MG TABLET?

Since Jun 1, 2022, the NADAC for CYPROHEPTADINE 4 MG TABLET has ranged from a low of $0.0644 (Apr 22, 2026) to a high of $0.1072 (Mar 13, 2024), with a median of $0.0836 per EA.

Are there cheaper alternatives to CYPROHEPTADINE 4 MG TABLET?

5 NADAC-published products share the same active ingredient, strength, and dosage form as CYPROHEPTADINE 4 MG TABLET, but none are currently priced below it.

Who manufactures CYPROHEPTADINE 4 MG TABLET?

CYPROHEPTADINE 4 MG TABLET (NDC 16571080501) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.

Related Drugs

Same classification

No related drugs found.